Authors
Latest:
Gwendolynn Harrell Discusses the Benefit of Identifying Symptom ClustersGwendolynn Harrell, RN, Palliative Care Nurse Liaison, Supportive Oncology Care Team, Emory University, discusses a study that examined symptom clustering among patients visiting a supportive oncology clinic.
Latest:
Jeannine Brant on Factors that Influence a Patient's Perception of PainJeannine Brant discusses factors that can influence a patient's perception of malignant pain.
Latest:
Nurse Leaders, Promote Resiliency During the PandemicThe wrath of the pandemic swept through our nation and continues to run rampant, testing our resiliency as nurses. Nurse leaders, we must continue to lead by example and remain a united front with our team.
Latest:
Dr. Cella on Patient-Reported Outcomes in a Clinical SettingDr. David Cella from Northwestern University Feinberg School of Medicine on Patient-Reported Outcomes in a Clinical Setting
Latest:
Erin Hofstatter answers: Who Should Get Genetic Counseling and Testing?Dr. Erin Hofstatter gives some "red flags" that indicate a patient or family member should consider genetic counseling and testing.
Latest:
Challenges and Hopes for Liquid Biopsies in Bladder CancerLiquid biopsies and other novel techniques have the potential to change the bladder cancer space. However, unanswered questions remain.
Latest:
Giving Patients a Voice through AdvocacyBeing an advocate might not only change your patients' lives but your life as well.
Latest:
Morganna Freeman on Side Effect Management in Clinical TrialsMorganna Freeman discusses how nurses can prepare for side effect management in clinical trials.
Latest:
Ignacio I. Wistuba on Nurses' Role in Molecular TestingIgnacio I. Wistuba, MD, chair of the department of Translational Molecular Pathologies at MD Anderson Cancer Center, discusses the role nurses play in the field of molecular testing.
Latest:
Screening and Management: Distress and the Nurse Navigator, Part IICancer and its treatment creates or aggravates psychosocial distress, while unresolved physical and practical problems can also add to the distress of patients attempting to complete their treatment and recovery.
Latest:
ASCO Updates Guidelines on Bone-Modifying Drugs in Breast CancerASCO releases new recommendations amid growing therapeutic options and fresh concerns about serious skeletal-related events.
Latest:
Mark Kris on New Therapies for Lung CancerMark Kris, MD, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses the benefits of new therapies for lung cancer.Â
Latest:
Karen Lee Discusses Patient's Expectations with ImmunotherapyKaren Lee, NP, explains the importance of keeping patients with cancer hopeful but realistic when starting immunotherapies.
Latest:
Joanne McGovern on Encouraging Nurses to Lead Research ProjectsJoanne McGovern, MSN, RN, CCRN, offers some tips on how to encourage nurses to create and implement their own research projects.
Latest:
How ctDNA Testing Is Being Used To Diagnose And Monitor CancerThe role of circulating tumor DNA is growing: From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
Latest:
Why Patients Are Apprehensive About Genetic TestingGenetic testing can be very beneficial to patients and their families. However, some people are still unsure about having it done.
Latest:
Nina Grenon Discusses the Impact of Early Palliative CareNina Grenon, RN, APRN, BC, nurse practitioner, Dana-Farber Cancer Institute, discusses the results of a study that looked at the effect of palliative care in patients with lung cancer.
Latest:
Penny Daugherty on Misinformation Surrounding Medical MarijuanaPenny Daugherty, RN, MSN, OCN, of Northside Hospital Cancer Institute, discusses the harmful and confusing misinformation that surrounds medical marijuana.
Latest:
Quality of Life Data for PARP Inhibitor Shows Promise for Pancreatic Cancer TreatmentResults from the randomized phase 3 POLO trial are in, and the quality of life data shows promise for patients with metastatic pancreatic cancer who harbor a germline BRCA gene mutation.
Latest:
How Nurses Can Forge a Path to the Boardroom and Improve HealthcareIn order to give life to a strategy, a nurse leader must understand the clinical environment and how patients and staff respond to various interventions.
Latest:
Dennise Geiger Discusses Telephone Triage in Cancer CareDennise Geiger, RN, Regional Cancer Care Associates, Central Jersey Division, discusses difficulties nurses face when using telephone triage, and the plan that was developed to better streamline the process.
Latest:
Jennifer Klemp on Measuring Survivorship OutcomesJennifer Klemp, PhD, MPH, discusses the importance of measuring outcomes in survivorship care for patients with cancer.
Latest:
Gwen Wyatt Discusses Conducting a Multisite Randomized TrialGwen Wyatt, PhD, RN, FAAN,discusses the challenges associated with conducting a multisite randomized clinical trial.
Latest:
Rudolph Navari on Traditional Treatment for CINVRudolph Navari, MD, PhD, professor of Medicine at Indiana University School of Medicine -South Bend, discusses traditional antiemetic treatment for chemotherapy-induced nausea and vomiting (CINV).
Latest:
Ovarian Suppression Combined with Tamoxifen May Help Premenopausal PatientsA phase III study found that adding 2 years of ovarian function suppression to tamoxifen extended disease-free survival in certain patients with hormone receptor-positive breast cancer.
Latest:
Joni Watson Discusses Her Experience With TwitterJoni Watson, MBA, MSN, RN, OCN, Director, Baylor Scott & White Cancer Center, discusses the opportunities Twitter can provide for oncology nurses.
Latest:
There's an App for That: Keeping Patients and Physicians on TrackUsing mobile apps and other new technologies, clinicians can better monitor and help their patients.
Latest:
Prognosis Discordance Prevalent Among Decision-Makers at the End-of-LifeResearchers conducted interviews of patients’ decision-makers to determine how well their understanding of a patient’s prognosis aligned with the physician’s prognostic estimate. The patients were receiving care in the intensive care unit and were identified by physicians as having a high risk of death.
